Cell BioEngines, Inc. (“Cell BioEngines” or the “Company”), a clinical-stage biotechnology company developing a universal ‘plug-and-play’ allogeneic stem cell therapy platform and a portfolio of ...
SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-enabled clean energy software and services, today announced that its Board of Directors ...
The Ethical and Versatile Potential of Induced Pluripotent Stem Cells (iPSCs)Boston, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Induced Pluripotent Stem Cells: ...
Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research ...